Opioid receptor subtypes: fact or artifact? N Dietis, DJ Rowbotham, DG Lambert British journal of anaesthesia 107 (1), 8-18, 2011 | 203 | 2011 |
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile N Dietis, R Guerrini, G Calo, S Salvadori, DJ Rowbotham, DG Lambert British journal of anaesthesia 103 (1), 38-49, 2009 | 195 | 2009 |
Opioid analgesia and opioid-induced adverse effects: a review AK Paul, CM Smith, M Rahmatullah, V Nissapatorn, P Wilairatana, ... Pharmaceuticals 14 (11), 1091, 2021 | 130 | 2021 |
Stress-based animal models of depression: Do we actually know what we are doing? X Yin, N Guven, N Dietis Brain Research 1652, 30-42, 2016 | 88 | 2016 |
Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells Y Gregoriou, G Gregoriou, V Yilmaz, K Kapnisis, M Prokopi, A Anayiotos, ... Nanotheranostics 5 (1), 113, 2021 | 76 | 2021 |
Ways to increase adherence to allergen immunotherapy C Pitsios, N Dietis Current Medical Research and Opinion 35 (6), 1027-1031, 2019 | 44 | 2019 |
Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19 M Tomazou, M Bourdakou, G Minadakis, M Zachariou, A Oulas, ... | 27 | 2021 |
Morphine dosing strategy plays a key role in the generation and duration of the produced antinociceptive tolerance AK Paul, N Gueven, N Dietis Neuropharmacology 121, 158-166, 2017 | 24 | 2017 |
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505 N Dietis, H Niwa, R Tose, J McDonald, V Ruggieri, M Filaferro, G Vitale, ... British journal of pharmacology 175 (14), 2881-2896, 2018 | 23 | 2018 |
A novel conjugate of bis [((4-bromophenyl) amino) quinazoline], a EGFR-TK ligand, with a fluorescent Ru (II)-bipyridine complex exhibits specific subcellular localization in … R Ilmi, E Tseriotou, P Stylianou, YA Christou, I Ttofi, N Dietis, C Pitris, ... Molecular pharmaceutics 16 (10), 4260-4273, 2019 | 19 | 2019 |
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505) N Dietis, J McDonald, S Molinari, G Calo, R Guerrini, DJ Rowbotham, ... British journal of anaesthesia 108 (2), 262-270, 2012 | 19 | 2012 |
Computational drug repurposing for neurodegenerative diseases K Savva, M Zachariou, A Oulas, G Minadakis, K Sokratous, N Dietis, ... In Silico Drug Design, 85-118, 2019 | 18 | 2019 |
Profiling the effects of repetitive morphine administration on motor behavior in rats AK Paul, N Gueven, N Dietis Molecules 26 (14), 4355, 2021 | 15 | 2021 |
Network-based stage-specific drug repurposing for Alzheimer’s disease K Savva, M Zachariou, MM Bourdakou, N Dietis, GM Spyrou Computational and Structural Biotechnology Journal 20, 1427-1438, 2022 | 13 | 2022 |
Age-dependent antinociception and behavioral inhibition by morphine AK Paul, N Gueven, N Dietis Pharmacology Biochemistry and Behavior 168, 8-16, 2018 | 10 | 2018 |
Gaps in knowledge about SARS-CoV-2 & COVID-19 among university students are associated with negative attitudes toward people with COVID-19: a cross-sectional study in Cyprus N Middleton, C Tsioutis, O Kolokotroni, A Heraclides, ... Frontiers in public health 9, 758030, 2021 | 9* | 2021 |
Opioid receptor-dependent modulation of insulin-release in pancreatic beta-cells A Paul, N Guven, N Dietis Pharmaceutical and Biosciences Journal, 22-31, 2014 | 9 | 2014 |
Strategies to reduce morphine tolerance in cancer: evaluation of the bifunctional opioid UFP-505 N Dietis University of Leicester, 2012 | 5 | 2012 |
Data on prolonged morphine-induced antinociception and behavioral inhibition in older rats AK Paul, N Gueven, N Dietis Data in Brief 19, 183-188, 2018 | 4 | 2018 |
Opioids in depression: not quite there yet X Yin, N Guven, N Dietis Pharmaceutical and Biosciences Journal, 12-17, 2015 | 4 | 2015 |